Graham Capital Management, L.P. Viking Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.11 - $3.15 $268,117 - $400,270
-127,070 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$3.0 - $4.88 $225,837 - $367,361
75,279 Added 145.35%
127,070 $381,000
Q4 2021

Feb 14, 2022
BUY
$4.6 - $6.72 $238,238 - $348,035
51,791 New
51,791 $238,000

Others Institutions Holding VKTX

# of Institutions
475
Shares Held
64.6M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.01B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email